Baillie Gifford & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46B | Buy |
|
|||||
|
2025
Q1 | $968M | Sell |
|
|||||
|
2024
Q4 | $1.14B | Sell |
|
|||||
|
2024
Q3 | $1.01B | Sell |
|
|||||
|
2024
Q2 | $1.74B | Sell |
|
|||||
|
2024
Q1 | $2.18B | Sell |
|
|||||
|
2023
Q4 | $2.05B | Sell |
|
|||||
|
2023
Q3 | $1.56B | Sell |
|
|||||
|
2023
Q2 | $2.15B | Sell |
|
|||||
|
2023
Q1 | $1.99B | Sell |
|
|||||
|
2022
Q4 | $1.96B | Sell |
|
|||||
|
2022
Q3 | $1.46B | Buy |
|
|||||
|
2022
Q2 | $1.35B | Sell |
|
|||||
|
2022
Q1 | $2.33B | Buy |
|
|||||
|
2021
Q4 | $2.42B | Sell |
|
|||||
|
2021
Q3 | $2.93B | Buy |
|
|||||
|
2021
Q2 | $2.23B | Sell |
|
|||||
|
2021
Q1 | $1.92B | Sell |
|
|||||
|
2020
Q4 | $2.02B | Buy |
|
|||||
|
2020
Q3 | $1.74B | Sell |
|
|||||
|
2020
Q2 | $1.84B | Sell |
|
|||||
|
2020
Q1 | $1.3B | Buy |
|
|||||
|
2019
Q4 | $1.05B | Sell |
|
|||||
|
2019
Q3 | $720M | Sell |
|
|||||
|
2019
Q2 | $725M | Sell |
|
|||||
|
2019
Q1 | $586M | Sell |
|
|||||
|
2018
Q4 | $591M | Sell |
|
|||||
|
2018
Q3 | $729M | Sell |
|
|||||
|
2018
Q2 | $494M | Sell |
|
|||||
|
2018
Q1 | $402M | Sell |
|
|||||
|
2017
Q4 | $319M | Sell |
|
|||||
|
2017
Q3 | $283M | Sell |
|
|||||
|
2017
Q2 | $446M | Sell |
|
|||||
|
2017
Q1 | $526M | Buy |
|
|||||
|
2016
Q4 | $366M | Buy |
|
|||||
|
2016
Q3 | $533M | Buy |
|
|||||
|
2016
Q2 | $38.2M | Buy |
|
|||||
|
2016
Q1 | $13.9M | Buy |
|
|||||
|
2015
Q4 | $10.9M | Hold |
|
|||||
|
2015
Q3 | $11.4M | Sell |
|
|||||
|
2015
Q2 | $11.4M | Sell |
|
|||||
|
2015
Q1 | $10.1M | Sell |
|
|||||
|
2014
Q4 | $13.9M | Sell |
|
|||||
|
2014
Q3 | $11.2M | Sell |
|
|||||
|
2014
Q2 | $12.7M | Buy |
|
|||||
|
2014
Q1 | $12.8M | Buy |
|
|||||
|
2013
Q4 | $2.8M | Buy |
|
|||||
|
2013
Q3 | $1.86M | Buy |
|
|||||
|
2013
Q2 | $673K | Buy |
|